Miguel Angel Lazaro
Overview
Explore the profile of Miguel Angel Lazaro including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
65
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Guerra-Rebollo M, Stampa M, Lazaro M, Cascante A, Fornaguera C, Borros S
J Neuromuscul Dis
. 2021 Aug;
8(5):815-825.
PMID: 34366365
Background: Duchenne Muscular Dystrophy (DMD) is one of the most common muscular dystrophies, caused by mutated forms of the dystrophin gene. Currently, the only treatment available is symptoms management. Novel...
2.
Brugada-Vila P, Cascante A, Lazaro M, Castells-Sala C, Fornaguera C, Rovira-Rigau M, et al.
Theranostics
. 2020 Mar;
10(6):2744-2758.
PMID: 32194832
Oncolytic adenoviruses are used as agents for the treatment of cancer. However, their potential is limited due to the high seroprevalence of anti-adenovirus neutralizing antibodies (nAbs) within the population and...
3.
In Vivo Retargeting of Poly(beta aminoester) (OM-PBAE) Nanoparticles is Influenced by Protein Corona
Fornaguera C, Guerra-Rebollo M, Lazaro M, Cascante A, Rubio N, Blanco J, et al.
Adv Healthc Mater
. 2019 Sep;
8(19):e1900849.
PMID: 31478348
One of the main bottlenecks in the translation of nanomedicines from research to clinics is the difficulty in designing nanoparticles actively vectorized to the target tissue, a key parameter to...
4.
Fornaguera C, Guerra-Rebollo M, Lazaro M, Castells-Sala C, Meca-Cortes O, Ramos-Perez V, et al.
Adv Healthc Mater
. 2018 Jun;
7(17):e1800335.
PMID: 29923337
The encapsulation of mRNA in nanosystems as gene vaccines for immunotherapy purposes has experienced an exponential increase in recent years. Despite the many advantages envisaged within these approaches, their application...
5.
Fornaguera C, Lazaro M, Brugada-Vila P, Porcar I, Morera I, Guerra-Rebollo M, et al.
Drug Deliv
. 2018 Feb;
25(1):472-483.
PMID: 29412012
Glioblastoma multiforme (GBM) is the most devastating primary brain tumor due to its infiltrating and diffuse growth characteristics, a situation compounded by the lack of effective treatments. Currently, many efforts...